5-HT2B antagonist-1

• CAT Number: I043433
• CAS Number: 393129-91-4
• Molecular Formula: C11H14BrN5
• Molecular Weight: 296.17
• Purity: ≥95%
• Synonyms: 2-N-(4-bromophenyl)-4,4-dimethyl-1H-1,3,5-triazine-2,6-diamine
• IUPAC Name: 4-[4-(4-tert-butylphenyl)sulfonylpiperazin-1-yl]-5,6-dimethylthieno[2,3-d]pyrimidine
• InChI: InChI=1S/C22H28N4O2S2/c1-15-16(2)29-21-19(15)20(23-14-24-21)25-10-12-26(13-11-25)30(27,28)18-8-6-17(7-9-18)22(3,4)5/h6-9,14H,10-13H2,1-5H3
• InChIKey: VDTGYRUIQQDQTL-UHFFFAOYSA-N
• SMILES: CC1=C(SC2=NC=NC(=C12)N3CCN(CC3)S(=O)(=O)C4=CC=C(C=C4)C(C)(C)C)C

5-HT2B antagonist-1（Cat No.:I043433）is a selective inhibitor that targets the 5-HT2B receptor, a subtype of serotonin receptors involved in various physiological processes. By blocking this receptor, the antagonist can influence vascular tone, smooth muscle contraction, and neurotransmission. It is studied for its potential therapeutic applications in conditions like cardiovascular diseases, fibrosis, and certain neurological disorders. 5-HT2B antagonist-1 may offer a safer alternative to other treatments by reducing unwanted side effects typically associated with serotonin receptor modulation, making it an attractive candidate for drug development.